AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(Full text of a statement. Contact details below.)
ZURICH, Feb. 28 /PRNewswire-FirstCall-AsiaNet/ -- Centerpulse will establish an independent Spine-Tech Business Unit responsible for Europe/Asia/Latin America.
This change takes effect at the beginning of March. The new unit will be headed by Dr. Thomas Zehnder, who has until now been responsible for the global coordination of the Spine-Tech Division, and will be based in Oberwinterthur, Switzerland.
The decision was made by Centerpulse's Board of Directors at its meeting today.
The duties of this new unit were previously embedded in Centerpulse's Orthopedics Division Europe/Asia/Latin America. Centerpulse Chairman and CEO Max Link: "In Europe, the spine implant sector is experiencing the highest growth rates of any of our business segments and deserves our fullest attention."
Thomas Zehnder, 35, will report directly to Max Link and will also continue to be responsible for the company's biologics activities. Mike McCormick will remain head of Spine-Tech USA.
Centerpulse's subsidiaries develop, produce, and distribute medical implants and biological materials for orthopedic, spinal, and dental markets worldwide. The product array includes artificial joints, dental implants, spinal implants and instrumentation.